Definitive Contract 75N93024C00054
Award Date
9/30/24
Potential Completion Date
9/29/25
Potential Value
$7.2M
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Phoenix, AZ 85004, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
12
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,472,866.08, was issued by the Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract provides bioinformatics support services, including genomic sequencing, analysis, and data services, to advance precision medicine research. TGen has previously conducted genomic research and analysis work for several federal agencies, such as the National...
This is a $3,202,949.00 federal contract awarded by the Department of Homeland Security (DHS) Science and Technology Directorate to the Translational Genomics Research Institute (TGen), a non-profit biomedical research organization. The contract is for research and development services to develop and validate a field-ready multiple amplicon sequencing system for detecting and characterizing five biothreat agents: Bacillus anthracis, Francisella tularensis, Yersinia pestis, Burkholderia...
This contract was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (CDC) to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract, valued at $109,504.00, is a Definitive Contract with a Firm Fixed Price under Broad Agency Announcement (BAA) 2017. The contract does not have a set-aside designation. Under this contract, TGen will provide a variety of genomic research services, including SARS-CoV-2...
This is a $145,000.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to the Translational Genomics Research Institute (TGen), a non-profit research organization. The contract is for RUN DATA SAMPLES services, with a completion date of September 29, 2024. TGen has previously performed genomic research services for federal agencies under both contracts and grants, including work related to SARS-CoV-2,...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to The Global Alliance For TB Drug Development Inc., a non-profit organization. The $9,851,406.00 cost-no-fee contract is for the development of a novel modulator targeting proteostasis for the treatment of M. tuberculosis, with a completion date of April 30, 2028. The contract was awarded under NIAID's Broad...
This is a $77,025 purchase order contract awarded by the Indian Health Service, a civilian agency within the U.S. Department of Health and Human Services, to the Translational Genomics Research Institute (TGen) for COVID-19 (SARS-CoV-2) testing and translational genomics research. The contract does not have a set-aside designation. TGen is a non-profit biomedical research organization that specializes in genomic analysis and bioinformatics to advance precision medicine. Through this contract,...
The National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $66,054.60 firm fixed-price purchase order to the Translational Genomics Research Institute (TGen), a non-profit research organization, for long-read RNA sequencing services. This contract, with a completion date of December 10, 2024, does not utilize any set-aside designations. TGen, which frequently collaborates with academic institutions and has received substantial...
This is a $13,047,673.64 definitive cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Mriglobal (doing business as Midwest Research Institute), a 501(c)(3) not-for-profit research organization. The contract is for the Mycobacterium Tuberculosis (MTB) Quality Assessment Program (TBQA), with a period of performance through December 31, 2023. This contract was not set aside for any specific business type. Mriglobal...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to Seattle Children's Hospital to conduct research on tuberculosis. The $87,790,431 contract, which has no set-aside designation, is for the "Immune Mechanisms of Protection Against Mycobacterium Tuberculosis Center (IMPAC-TB)". The prime contractor is Seattle Children's Hospital, doing business as Seattle Children's Research Institute, a...
This is a $37,252,988 definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Seattle Children's Hospital, doing business as Seattle Children's Research Institute, for the "IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)" project. The contract has a period of performance through July 31, 2028 and does not utilize any set-aside designations. The contract supports research to examine innate and adaptive...